posted on 2012-11-01, 00:00authored byS Wickremasinghe, S Sandhu, Ljoudmila Busija, J Lim, D Chauhan, R Guymer
A letter to the editor that refers to the following article :
Frank G. Holz, Winfried Amoaku, Juan Donate, Robyn H. Guymer, Ulrich Kellner, Reinier O. Schlingemann, Andreas Weichselberger, Giovanni Staurenghi, SUSTAIN Study Group. Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study Ophthalmology, Volume 118, Issue 4, April 2011, Pages 663-671